OSTX (STOCKS)
OS Therapies Incorporated
$1.710000
+0.010000 (+0.59%)
Prev close: $1.700000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul A. Romness
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $76.16M
- Employees
- 5
- P/E (TTM)
- -1.67
- P/B (TTM)
- -6.24
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.27 | $-0.18 | -0.0898 | -49.83% |
|
Mar 2025 (Q4)
|
$-0.50 | $-0.14 | -0.3613 | -260.49% |
|
Sep 2025 (Q3)
|
$-0.21 | $-0.13 | -0.0825 | -64.71% |
|
Jun 2025 (Q2)
|
$-0.19 | $-0.12 | -0.0727 | -61.98% |
Financial Statements
| Nonoperating Income/Loss | -$1.40M |
| Depreciation and Amortization | $487.33K |
| Research and Development | $22.40M |
| Operating Income/Loss | -$33.87M |
| Income/Loss From Continuing Operations After Tax | -$35.27M |
| Income/Loss From Continuing Operations Before Tax | -$35.27M |
| Net Income/Loss | -$35.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$35.27M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.27M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.08 |
| Diluted Earnings Per Share | -$1.08 |
| Diluted Average Shares | 97,608,629 |
| Assets | $7.30M |
| Current Assets | $917.55K |
| Noncurrent Assets | $6.38M |
| Fixed Assets | $1.80K |
| Other Non-current Assets | $6.38M |
| Liabilities | $17.05M |
| Current Liabilities | $16.95M |
| Noncurrent Liabilities | $100.00K |
| Equity | -$10.82M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$10.82M |
| Temporary Equity | $1.07M |
| Temporary Equity Attributable To Parent | $1.07M |
| Liabilities And Equity | $7.30M |
| Net Cash Flow From Operating Activities | -$15.36M |
| Net Cash Flow From Operating Activities, Continuing | -$15.36M |
| Net Cash Flow From Investing Activities | -$940.51K |
| Net Cash Flow From Investing Activities, Continuing | -$940.51K |
| Net Cash Flow From Financing Activities | $13.60M |
| Net Cash Flow From Financing Activities, Continuing | $13.60M |
| Net Cash Flow | -$2.70M |
| Net Cash Flow, Continuing | -$2.70M |
| Comprehensive Income/Loss | -$35.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$35.27M |
| Other Comprehensive Income/Loss | $0.00 |